Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ENDRA Life Sciences (NDRA) Long-Term Deferred Tax (2016 - 2020)

ENDRA Life Sciences (NDRA) has disclosed Long-Term Deferred Tax for 3 consecutive years, with $11.3 million as the latest value for Q4 2020.

  • Quarterly Long-Term Deferred Tax changed N/A to $11.3 million in Q4 2020 from the year-ago period, while the trailing twelve-month figure was $11.3 million through Dec 2020, changed N/A year-over-year, with the annual reading at $11.3 million for FY2020, N/A changed from the prior year.
  • Long-Term Deferred Tax for Q4 2020 was $11.3 million at ENDRA Life Sciences, up from $4.0 million in the prior quarter.
  • The five-year high for Long-Term Deferred Tax was $11.3 million in Q4 2020, with the low at $3.8 million in Q4 2016.
  • Average Long-Term Deferred Tax over 3 years is $6.4 million, with a median of $4.0 million recorded in 2017.
  • Peak annual rise in Long-Term Deferred Tax hit 5.75% in 2017, while the deepest fall reached 5.75% in 2017.
  • Over 3 years, Long-Term Deferred Tax stood at $3.8 million in 2016, then increased by 5.75% to $4.0 million in 2017, then soared by 180.64% to $11.3 million in 2020.
  • According to Business Quant data, Long-Term Deferred Tax over the past three periods came in at $11.3 million, $4.0 million, and $3.8 million for Q4 2020, Q4 2017, and Q4 2016 respectively.